A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 1, 2014, Pages 226-237

  Narvekar, Mayuri ^a   Xue, Hui Yi ^a   Tran, Ngoc T ^a   Mikhael, Mariam ^a   Wong, Ho Lun ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

All trans retinoic acid; Chemoresistance; Controlled drug delivery; Nanomedicine; Ovarian cancer; Poorly water soluble drugs

Indexed keywords

EID: 84900768251     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.04.014     Document Type: Article

References (35)

1. R.F. Ozols Systemic therapy for ovarian cancer: current status and new treatments Semin. Oncol. 33 2006 S3 S11
2. C. Tian, C.B. Ambrosone, K.M. Darcy, T.C. Krivak, D.K. Armstrong, M.A. Bookman, W. Davis, H. Zhao, K. Moysich, H. Gallion, and J.A. DeLoia Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a gynecologic oncology group study Gynecol. Oncol. 124 2012 575 581
3. G.Y. Hong, Y.I. Jeong, S.J. Lee, E. Lee, J.S. Oh, and H.C. Lee Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma Arch. Pharm. Res. 34 2011 407 417
4. F. Ravandi Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapy Oncology 25 2011 741 743
5. Siddikuzzaman, C. Guruvayoorappan, and V.M. Berlin Grace All trans retinoic acid and cancer Immunopharmacol. Immunotoxicol. 33 2011 241 249
6. R. Masetti, F. Vendemini, D. Zama, C. Biagi, P. Gasperini, and A. Pession All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia Expert Rev. Anticancer Ther. 12 2012 1191 1204
7. A. Chinsriwongkul, P. Chareanputtakhun, T. Ngawhirunpat, T. Rojanarata, W. Sila-on, U. Ruktanonchai, and P. Opanasopit Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug AAPS PharmSciTech 13 2012 150 158
8. Y. Li, X.R. Qi, Y. Maitani, and T. Nagai PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations Nanotechnology 20 2009 055106
9. S.J. Um, S.Y. Lee, E.J. Kim, H.S. Han, Y.M. Koh, K.J. Hong, H.S. Sin, and J.S. Park Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells Cancer Lett. 174 2001 127 134
10. Chinsriwongkul, P. Opanasopit, T. Ngawhirunpat, N. Chareansriwilaiwat, W. Sila-On, and U. Ruktanonchai Physicochemical properties of lipid emulsions formulated with high-load all-trans-retinoic acid PDA J. Pharm. Sci. Technol. 61 2007 461 471
11. J. Su, N. Zhang, and P.C. Ho Evaluation of the pharmacokinetics of All-Trans-Retinoic Acid (ATRA) in wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines J. Pharm. Sci. 97 2008 2844 2853
12. S. Kawakami, P. Opanasopit, M. Yokoyama, N. Chansri, T. Yamamoto, T. Okano, F. Yamashita, and M. Hashida Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration J. Pharm. Sci. 94 2005 2606 2615
13. A. Chinsriwongkul, P. Opanasopit, T. Ngawhirunpat, T. Rojanarata, W. Sila-On, and U. Ruktanonchai Oleic acid enhances all-trans retinoic acid loading in nano-lipid emulsions PDA J. Pharm. Sci. Technol. 64 2010 113 123
14. M. Narvekar, H.Y. Xue, and H.L. Wong A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA) Int. J. Pharm. 436 2012 721 731
15. B. Thibault, M. Castells, J.P. Delord, and B. Couderc Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition Cancer Metastasis Rev. 2013 (Epub ahead of print)
16. A. Alisi, W.C. Cho, F. Locatelli, and D. Fruci Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma Int. J. Mol. Sci. 14 2013 24706 24725
17. R. Karki, B.L. Seagle, W. Nieves-Neira, and S. Shahabi Taxanes in combination with biologic agents for ovarian and breast cancers Anticancer Drugs 2013 (Epub ahead of print)
18. S. Hille, D.T. Rein, M. Riffelmann, R. Neumann, J. Sartorius, A. Pfützner, C.M. Kurbacher, T. Schöndorf, and M. Breidenbach Anticancer drugs induce MDR1 gene expression in recurrent ovarian cancer Anticancer Drugs 17 2006 1041 1044
19. H.L. Wong, R. Bendayan, A.M. Rauth, H.Y. Xue, K. Babakhanian, and X.Y. Wu A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system J. Pharmacol. Exp. Ther. 317 2006 1372 1381
20. M.D. Curley, V.A. Therrien, C.L. Cummings, P.A. Sergent, C.R. Koulouris, A.M. Friel, D.J. Roberts, M.V. Seiden, D.T. Scadden, B.R. Rueda, and R. Foster CD133 expression defines a tumor initiating cell population in primary human ovarian cancer Stem Cells 27 2009 2875 2883
21. F. Danhier, E. Ansorena, J.M. Silva, A. Le Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
22. Z. Sulová, D. Macejová, M. Seres, J. Sedlák, J. Brtko, and A. Breier Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity Toxicol. In Vitro 22 2008 96 105
23. W.L. Suen, and Y. Chau Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells J. Pharm. Pharmacol. 66 2014 564 573
24. E.E. Oldridge, H.F. Walker, M.J. Stower, M.S. Simms, V.M. Mann, A.T. Collins, D. Pellacani, and N.J. Maitland Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN Oncogenesis 2 2013 e45
25. L.C. Chee, J. Hendy, L.E. Purton, and G.A. McArthur ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells Leukemia 27 2013 1369 1380
26. M.A. Iqbal, S. Md, J.K. Sahni, S. Baboota, S. Dang, and J. Ali Nanostructured lipid carriers system: recent advances in drug delivery J. Drug Target. 20 2012 813 830
27. G. Clemens, K.R. Flower, P. Gardner, A.P. Henderson, J.P. Knowles, T.B. Marder, A. Whiting, and S. Przyborski Design and biological evaluation of synthetic retinoids: probing length vs. stability vs. activity Mol. BioSyst. 9 2012 3124 3134
28. W. Yu, and C.M. Burns All-trans retinoic acid-induced focal myositis, synovitis, and mononeuritis J. Clin. Rheumatol. 15 2009 358 360
29. B.C. de-Medeiros, E. Strapasson, R. Pasquini, and C.R. de-Medeiros Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center Braz. J. Med. Biol. Res. 31 1998 1537 1543
30. J.L. Armstrong, G.A. Taylor, H.D. Thomas, A.V. Boddy, C.P.F. Redfern, and G.J. Veal Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo Br. J. Cancer 96 2007 1675 1683
31. X. Han, F. Du, L. Jiang, Y. Zhu, Z. Chen, Y. Liu, T. Hong, T. Wang, Y. Mao, X. Wu, I.C. Bruce, J. Jin, X. Ma, and D. Hua A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties Oncol. Lett. 6 2013 1295 1298
32. R. Strauss, Z.Y. Li, Y. Liu, I. Beyer, J. Persson, P. Sova, T. Moller, S. Pesonen, A. Hemminki, P. Hamerlik, C. Drescher, N. Urban, J. Bartek, and A. Lieber Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity PLoS ONE 2011 10.1371/journal.pone.0016186
33. H.L. Wong, R. Bendayan, A.M. Rauth, Y. Li, and X.Y. Wu Chemotherapy with anticancer drugs entrapped into solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 491 504
34. A. Cambón, J. Brea, M.I. Loza, C. Alvarez-Lorenzo, A. Concheiro, S. Barbosa, P. Taboada, and V. Mosquera Cytocompatibility and P-glycoprotein inhibition of block copolymers: structure-activity relationship Mol. Pharm. 10 2013 3232 3241
35. N.T. Tran, H.Y. Xue, M. Narvekar, S. Liu, H.L. Wong, Development and evaluation of a new nanostructured carrier for docetaxel delivery to advanced stage cancers. AAPS Meeting 2013, W4005. < http://abstracts.aaps.org/published/ContentInfo.aspx?conID=44489 >.